Business Description
IR-Med Inc
NAICS : 325413
SIC : 5047
ISIN : US46265R1032
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.84 | |||||
Equity-to-Asset | 0.37 | |||||
Debt-to-Equity | 0.55 | |||||
Debt-to-EBITDA | -0.04 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -86.2 | |||||
3-Year EPS without NRI Growth Rate | -85.3 | |||||
3-Year FCF Growth Rate | -98.6 | |||||
3-Year Book Growth Rate | -39 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 13.36 | |||||
9-Day RSI | 24.69 | |||||
14-Day RSI | 30.55 | |||||
6-1 Month Momentum % | 30.4 | |||||
12-1 Month Momentum % | 226.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.79 | |||||
Quick Ratio | 1.79 | |||||
Cash Ratio | 1.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.7 | |||||
Shareholder Yield % | 0.1 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -310.81 | |||||
ROA % | -221.91 | |||||
ROIC % | -1499.08 | |||||
ROC (Joel Greenblatt) % | -2728.33 | |||||
ROCE % | -295.91 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 90 | |||||
Price-to-Tangible-Book | 90 | |||||
EV-to-EBIT | -13.41 | |||||
EV-to-EBITDA | -13.46 | |||||
EV-to-FCF | -20.79 | |||||
Earnings Yield (Greenblatt) % | -7.46 | |||||
FCF Yield % | -5.14 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IRME
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
IR-Med Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -0.08 | ||
Beta | 1.89 | ||
Volatility % | 182.82 | ||
14-Day RSI | 30.55 | ||
14-Day ATR ($) | 0.048677 | ||
20-Day SMA ($) | 1.1401 | ||
12-1 Month Momentum % | 226.08 | ||
52-Week Range ($) | 0.3501 - 1.651 | ||
Shares Outstanding (Mil) | 69.93 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
IR-Med Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
IR-Med Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
IR-Med Inc Frequently Asked Questions
What is IR-Med Inc(IRME)'s stock price today?
When is next earnings date of IR-Med Inc(IRME)?
Does IR-Med Inc(IRME) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |